Substituted 6-membered N-heterocyclic compounds and method...

Details Substituted 6-membered N-heterocyclic compounds and method... Substituted 6-membered N-heterocyclic compounds and method...

2007-12-04

2007-12-04

Habte, Kahsay (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S227800, C544S058200

Reexamination Certificate

active

10497876

ABSTRACT:
This invention relates to substituted 6-membered N-Herterocyclic neurotrophic compounds of formula (I) or pharmaceutically acceptable salts or hydrates thereof, wherein R1, R2, X, Y, and Z are as defined in the description; their preparation methods, compositions comprising the same, and their use as inhibitors of FK560 binding proteases activity for treating and preventing neurodegenerative diseases and other nerve disorders associated with nerve injuries or other related diseases

REFERENCES:
patent: 5798355 (1998-08-01), Steiner et al.
patent: WO96/40140 (1996-12-01), None
patent: WO9914988 (1999-04-01), None
patent: WO9962880 (1999-12-01), None
patent: WO00/09104 (2000-02-01), None
patent: WO00/09109 (2000-02-01), None
Starzl, T.E., et al. “FK-506: A potential breakthrough in immunosuppression”.Transplant Proc, 1987, 19: S3-S104.
Maki N., et al. “Complementary DNA encoding the human T-cell FK506-binding protein, a peptidylprolyl cis-trans isomerase distinct from cyclophilin”.Proc Natl Acad Sci USA, 1990, 87:5440-5443.
Steiner, J.P, et al. “High brain densities of the immunophilin FKBP colocalized with calcineurin”Nature, 1992, 358: 584-587.
Sharkey, J., et al. “Immunophilins mediate the neuroprotective effects of FK506 in focal celebral ischaemia.”Nature, 1994, 371: 336-339.
Lyons, W.E., et al. “Immunosuppresant FK506 promotes neurite outgrowth in cultures of PC-12cells and sensory ganglia”.ProcNatl Acad Sci USA, 1994, 91: 3191-3195.
Gold, B.G., et al. “The immunosuppressant FK506 increases functional recovery and nerve regeneration following peripheral nerve in jury”.Restor Neurol Neurosci, 1994, 6: 287-296.
Gold B.G., et al. “The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve.”J Neurosci, 1995, 15: 7509-7516.
Kopp J B, et al. “Cellular and molecular mechanisms of cyclosporin nephrotoxicity.”J Am Soc Nephrol, 1990, 1:162-179.
De Groen, P.C., et al. “Central nervous system toxicity after liver transplantation.”N Engl J Med, 1987, 317: 861-866.
Kahan, B.D. “Drug therapy: cyclosporine”.N Engl J Med, 1989, 321: 1725-1738.

Affiliated with

Also associated with

Rating

Substituted 6-membered N-heterocyclic compounds and method... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted 6-membered N-heterocyclic compounds and method..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 6-membered N-heterocyclic compounds and method... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3892183